Infinium Pharmachem Limited — Updates, 16-01-2026: Press Release
16-01-2026 | 11:48 am
16-01-2026 | 11:48 am
Infinium Pharmachem has commissioned its new contrast media raw materials facility, a key forward integration. This move targets ₹100 Cr annual revenue within 3 years at ~30% EBITDA margin, expected to boost blended EBITDA to ~20%.
No comments yet. Be the first to comment!
